IP Verse

Ophthalmic Suspension Composition - EP3470059

The patent EP3470059 was granted to Bausch & Lomb Incorporated on Apr 1, 2020. The application was originally filed on Jan 26, 2016 under application number EP18209003A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3470059

BAUSCH & LOMB INCORPORATED
Application Number
EP18209003A
Filing Date
Jan 26, 2016
Status
Granted And Under Opposition
Feb 28, 2020
Grant Date
Apr 1, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANDOZDec 30, 2020KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (12) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS4540930
DESCRIPTIONUS4615697
DESCRIPTIONUS4996335
DESCRIPTIONUS5192535
DESCRIPTIONUS5538721
DESCRIPTIONWO8906964
OPPOSITIONWO2013043387
SEARCHEP0659433
SEARCHUS2013303502
SEARCHUS2014328917
SEARCHWO2004006959
SEARCHWO2013043387

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- SCHOENWALD RD; HARRIS RG; TURNER D et al., "Ophthalmic bioequivalence of steroid/antibiotic combination formulations", Biopharm Drug Dispos., (19870000), vol. 8, pages 527 - 548-
DESCRIPTION- TANG-LIU DD; BURKE PJ, "The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments", Pharm Res., (19880000), vol. 5, pages 238 - 241-
DESCRIPTION- LIU et al., "Nanosuspensions of poorly soluble drugs: preparation and development by wet milling", Int. J. of Pharm, (20110000), vol. 411, no. 1-2, doi:doi:10.1016/j.ijpharm.2011.03.050, pages 215 - 222, XP055143914
OPPOSITION- Abdulganee Memon, P. U. Patel, H. M. Sheth, "Optimization of Formulation Parameters on Ocular Loteprednol Etabonate Nanosuspension by Media Milling Method", International Journal of Pharmaceutical & Biological Archives, (20120101), vol. 4, no. 1, ISSN 0976-3333, pages 46 - 51, XP055643061-
OPPOSITION- Anonymous, "Results positive for B+L sub-micron gel formulation of loteprednol etabonate", Ophthalmology Times, (20140930), Ophthalmology Times, URL: https://www.ophthalmologytimes.com/modern-medicine-feature-articles/results-positive-bl-sub-micron-gel-formulation-loteprednol-etabonate, (20191107), XP055639922-
OPPOSITION- Gourav Rajoria, Gupta Arushi, "In-Situ Gelling System: A Novel Approach for Ocular Drug Delivery", American Journal of PharmTech Research, (20120101), vol. 2, no. 4, ISSN 2249-3387, pages 24 - 53, XP055643055-
OPPOSITION- Megan E Cavet, Shellise Glogowski Et Al., "Ocular pharmacokinetics of submicron loteprednol etabonate ophthalmic gel, 0.38% following topical administration in rabbits", ARVO Annual Meeting Abstract, (20150601), ARVO Annual Meeting Abstract, URL: https://iovs.arvojournals.org/article.aspx?articleid=2331235&resultClick=1, (20191115), XP055643069-
OPPOSITION- Phillips Eric, "Viscoelastic and dissolution characterization of submicron loteprednol etabonate ophthalmic gel, 0.38% ", ARVO Journals, (20150601), pages 1 - 2, ARVO Journals, URL: https://iovs.arvojournals.org/article.aspx?articleid=2331236, (20220928), XP055965893-
OPPOSITION- Prasanna Lakshmi, Giddam Ashwini Kumar, "NANO­-SUSPENSION TECHNOLOGY: A REVIEW", International Journal of Pharmacy and Pharmaceutical Sciences, (20100101), vol. 2, no. Suppl.4, pages 35 - 40, XP055643057-
OPPOSITION- ROWE R C; SHESKEY P J; OWEN S C (ED), "Handbook of Pharmaceutical Excipients, Hypromellose, Sorbitol", ROWE R C; SHESKEY P J; OWEN S C (ED), ROWE R.C., SHESKEY P.J., OWEN S.C.(EDS.), Handbook of Pharmaceutical Excipients, London [u.a.] , Pharmaceutical Press [u.a.] , (20060101), pages 346 - 349 + 718, 031835, ISBN 978-1-58212-058-4, XP002528077-
OPPOSITION- Schopf Lisa R., Popov Alexey M., Enlow Elizabeth M., Bourassa James L., Ong Winston Z., Nowak Pawel, Chen Hongming, "Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles", Translational Vision Science & Technology, Association for Research in Vision and Ophthalmology, US, US , (20150611), vol. 4, no. 3, doi:10.1167/tvst.4.3.11, ISSN 2164-2591, page 11, XP055965894
OPPOSITION- Martin J Coffey, Heleen H Decory, Stephen S Lane, "Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop", Clinical Ophthalmology, (20130101), no. 7, doi:10.2147/OPTH.S40588, pages 299 - 312, XP055643072

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents